Maximus Inc (MMS)

NYSE · Industrials · Specialty Business Services · USA

Maximus Inc is a mid cap company (market value between $2 billion and $10 billion) in the Specialty Business Services industry.

Maximus provides government agencies in the U.S., U.K., Canada, and the Middle East with technology-enabled services. The company delivers program operations, clinical assessments, and technology solutions for federal and state health, human services, and employment initiatives, including health insurance eligibility support, medical disability examinations, and contact center operations.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Maximus Inc stock.

Our verdict on MMS

Undervalued: intrinsic value $142.41 per share, market price $63.72, margin of safety 55.3% (as of 2026-10-30).

Discounting its cash flows at 7.5% (average of 3 methods) values the shares at $142.41; the price of $63.72 is 55% below that value, and 81% of that value comes from beyond year five.

Leak Score: 93/100 on 12 of 12 signals (Major Leak).

ETFs with the most weight in MMS

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Specialty Business Services

All 44 Specialty Business Services stocks

Cheaper than MMS in Specialty Business Services

Is MMS undervalued or overvalued?

MMS is undervalued (as of the 2026-10-30 close). Discounting its cash flows at 7.5% (average of 3 methods) values the shares at $142.41; the price of $63.72 is 55% below that value, and 81% of that value comes from beyond year five.

What is the intrinsic value of MMS?

$142.41 per share (as of the 2026-10-30 close), against a market price of $63.72. That is a margin of safety of 55.3%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Maximus Inc's Leak Score?

93 out of 100, which we rate "Major Leak", on 12 of 12 value investing signals.